Skip to content
EJP RD – European Joint Programme on Rare Diseases EJP RD – European Joint Programme on Rare Diseases
x
  • What is EJP RD?
    • Project structure
    • EJP RD Impact
    • Beneficiaries
    • Governance
    • Our publications
    • EJP RD Coordination Team
    • Careers
    • Privacy policy
  • Our actions and services
    • FUNDING OPPORTUNITIES
      • Open Funding Opportunities
      • Past Funding Opportunities
      • Funded projects
    • PATIENTS IN RESEARCH
    • VIRTUAL PLATFORM OF DATA AND RESOURCES
      • What is the virtual platform?
      • What do we do?
      • Resources for RD Research
      • FAIRification
      • Services and Events
    • TRAINING
      & EDUCATION
      • General Information on Training
      • RD Research Training
      • Patients Training
      • ERN Workshops
      • Online Academic Education Course
    • RESEARCH TRANSLATION SUPPORT OFFICE
      • Innovation Management Toolbox
      • Mentoring for Translational Research
      • Follow-on funding support
    • CLINICAL STUDIES SUPPORT OFFICE
      • Support office
      • Rare Diseases Clinical Trials Toolbox
      • Clinical Trials Methodology
    • ETHICS & REGULATORY ADVICE
      • Introduction to AREB
      • Key Ethics & Regulatory Documents
      • ERN Registries Generic Informed Consent Forms
  • News and events
    • News
    • EJP RD Events
    • Other RD Events
    • EJP RD Newsletter
  • Helpdesk

Tag: ema

EJP RD - European Joint Programme on Rare Diseases - News and events - News - ema
  • 07 Oct
  • 2022

EMA pilot offers enhanced support to academic and non-profit developers of advanced therapy medicinal products

  • News

EMA is launching a pilot to support the translation of basic research developments into medicines that could make a difference […]

Read More
  • 27 Jul
  • 2022

EMA recommends new medicine for multiple myeloma patients with limited treatment options

  • News

The European Medicines Agency (EMA) has recommended a conditional marketing authorisation in the European Union (EU) for Tecvayli (teclistamab), a monoclonal antibody […]

Read More
  • 11 Jul
  • 2022

EMA grants marketing authorisation to rare disease therapies

  • Uncategorized

In the months of May and June 2022, the European Medicines Agency (EMA) recommended granting various forms of marketing authorisation […]

Read More
  • 06 Apr
  • 2022

Live broadcast of Joint EMA/HMA/TEHDAS Data Quality Framework for Medicines workshop

  • News

The European Medicines Agency (EMA) is organising a joint EMA/HMA/TEHDAS Data Quality Framework for Medicines workshop as a virtual meeting on […]

Read More
  • 07 Feb
  • 2022

EMA webinar on repurposing of authorised medicines pilot programme

  • News

In October 2021, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) announced a pilot project to support the repurposing of […]

Read More
  • 01 Feb
  • 2022

EMA’s Clinical Trials Information System (CTIS) goes live

  • News

The European Medicines Agency’s (EMA) Clinical Trials Information System (CTIS) has gone live as of January 31st. CTIS is the […]

Read More
  • 13 Dec
  • 2021

EMA Webinar: Research in regulatory science – addressing the needs

  • News

The European Medicines Agency (EMA) is organising a virtual event on “Research in regulatory science – addressing the needs” to […]

Read More
  • 29 Oct
  • 2021

European Medicines Agency (EMA) launches pilot project on drug repurposing

  • News

The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) are launching a pilot project to support the repurposing of […]

Read More
  • 28 May
  • 2021

EMA recommends approval for first gene therapy to treat children with rare inherited neurological disease

  • News

Based on evidence from a single-arm clinical trial, the European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European […]

Read More
  • 26 Mar
  • 2021

Call for expression of interest – Data Standards Strategy survey and workshop

  • News

The Big Data Steering Group has launched an initiative to develop a Data Standards Strategy that will enable the Network to more […]

Read More
  • 1
  • 2

Search

Categories

  • EJP RD News
  • ERN-Research (ERICA)
  • Networking events funded by EJP RD
  • News
  • Uncategorized

Popular Tags

biobank clinical research clinical trial conference data sharing diagnostics drug repurposing duchenne EJPRD ema ERICA ERN ern research training workshops european commission EURORDIS event FAIR fda funding funding opportunity gene therapies genomics health data innovation irdirc MOOC networking networking event networking support scheme NSS OMP regulation open call orphan drugs paediatric patient patients rare diseases registry report survey symposium training virtual event webinar workshop

Latest Posts

  • New EJP RD – ERN Workshop: Desmoid tumors (DTs) in patients with Familial Adenomatous Polyposis (FAP): an interdisciplinary approach
  • Satisfaction Survey for EJP RD services
  • Training on Strategies to Foster Solutions of Undiagnosed Rare Disease Cases: Registration Open
  • AFM-Téléthon launches Scientific and Medical Research Call for Proposals for 2023
  • EJP RD Joint Transnational Call 2023: Now Open!

Featured Links

  • Helpdesk
  • Sitemap
  • Careers

Where we are

  • EJP RD INSERM Hôpital Charles-Foix
    7 avenue de la République
    94200 Ivry-sur-Seine
    France

The EJP RD initiative has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement N°825575

© Copyright EJP RD.
×
You must be logged in before using WishList. To login click here